Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Scope and Methodology
- Market Considerations
- Trends Affecting Infectious Disease Diagnosis Applications
- Opportunity for Diagnostic Products in Infectious Disease
- Drug Resistance
- Have Immunoassays Peaked?
- Need for Faster Tests
- “Controlled Growth” of NAT
- Drug Susceptibility and Resistance Testing Markets
- A Need for Simplification
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- General
- Infectivity
- Primary Pathogens
- Zoonoses
- Opportunistic Pathogens
- Disease Susceptibility
- Bacterial Infections
- Viral Infections
- Swine Flu and the IVD Industry
- Origin of Flu Virus Mixes
- PCR Test Development
- Late-Breaking Research Developments
- Use of Rapid Tests in Current Epidemic
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- Bacterial Cultures: Diagnosis and Susceptibility
- Blood Culture
- Throat Culture
- Sputum Cultures
- Spinal Fluid Cultures
- Stool Cultures
- Urine Cultures
- Viral Culture
- Immunoassays
- Agglutination Immunoassays
- Nephelometry
- Indirect Immunofluorescence
- Enzyme Immunoassay (ELISA, EIA)
- Fluorescence and Luminescence Immunoassay
- Magnetic Immunoassay
- Molecular Diagnostics
- Amplification Technologies
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- Increasing Use of Non-Traditional Systems
- FISH
- Cell Counting by Flow Cytometry
- Laser Based Microbial Detection
- Market Analysis
- Microbial Identification and Antimicrobial Sensitivity Tests
- Rapid Tests
- Immunoassays - Lab based
- STDs
- Supplies
- Competition
- Key Company Synopses
- AdvanDx
- Beckman Coulter
- bioMerieux
- BioRad -
- Cepheid -
- Gen-Probe
- Roche Molecular Diagnostics
- Siemens Healthcare Diagnostics -
CHAPTER FIVE: CONCLUSIONS AND STRATEGIC IMPLICATIONS
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
GLOSSARY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY:
- Figure 1-1: Worldwide Infectious Disease Diagnostics Sales
- Figure 1-2: Trend in Revenue in Infectious Disease Diagnostics Long-Term
(NAT, Rapid, Immunoassays)
CHAPTER TWO: OVERVIEW OF INFECTIOUS DISEASES
- Table 2-1: Classification of Common Pathogenic Bacteria
- Table 2-2: Common Mechanisms of Antibacterial Resistance
CHAPTER THREE: TECHNOLOGY AND PRODUCTS
- Table 3-1: Key Immunoassay Products Used for Clinical Testing for
Bacterial Infections
- Table 3-2: Molecular Diagnostics Technologies
- Table 3-3: Gene Amplification Technologies
- Table 3-4: Commonly Used Signal Amplification Technologies for Genetic
Analysis
- Table 3-5: Key Molecular Assay Products for the Diagnosis of Infectious
Diseases (Company, Analyte, Test Category, Product, Technology)
- Table 3-6: Key “Home Brew” Molecular Assays for Infectious
Diseases
CHAPTER FOUR: INFECTIOUS DISEASE DIAGNOSTICS MARKETS
- Table 4-1: Companies Engaged in the Market for Bacterial Culture Products
- Table 4-1: PCR, FISH, Flow and Cell Imaging Systems for Bacteria / Virus
Detection, 2008 and 2012 ($million)
- Table 4-2: Worldwide Microbiology/Virology Sales by Type (Immunoassays,
Rapid, DNA, ID/MIC ) 2008-2013
- Table 4-3 : ID/MIC Revenue Breakdown (Automated Panels and Reagents,
Manual Panels and Reagents, Blood Culture, Rapid Micro) and Supplies
- Table 4-4: Selected Chromogenic Growth Media (Company, Location, Media)
|
Related Report
|
View Cart
